(Q37031456)

17 August 2017

1 reference

title

Laboratory investigations including liver in polymyalgia rheumatica/giant cell arteritis (English)

1 reference

17 August 2017

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

30 November 2022

author name string

V. Kyle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1807822

30 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1807822

30 November 2022

publication date

1 December 1991

1 reference

full work available at URL

17 August 2017

https://api.elsevier.com/content/article/PII:S0950357905800664?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

https://api.elsevier.com/content/article/PII:S0950357905800664?httpAccept=text/plain

30 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

Bailliere's clinical rheumatology

30 November 2022

published in

1 reference

17 August 2017

volume

5

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

475-484

1 reference

Pathological changes in temporal arteries removed from unselected cadavers

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Skip areas in temporal arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Histologic and ultrastructural characteristics of temporal arteritis. The value of the temporal artery biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Giant-cell arteritis. A biopsy study of polymyalgia rheumatica, including one case of Takayasu's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Temporal artery biopsy and corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Temporal artery biopsy in giant-cell arteritis. A reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Acute phase reactants in the initial phase of giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Giant cell arteritis. Clinical features and involvement of different organs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

An evaluation of criteria for polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Steroid-responsive electromyographic abnormalities in polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Behaviour of von Willebrand factor antigen in follow-up of polymyalgia rheumatica/giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Influence of non-steroidal anti-inflammatory drugs and disease activity on serum alkaline phosphatase concentrations in rheumatoid arthritis, osteoarthritis, and polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Polymyalgia rheumatica: an arthroscopic study of the shoulder joint

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Elevation of von willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Immunohistochemical findings in cranial arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Arteritis of the aged (giant cell arteritis) and fever of unexplained origin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Letter: Polymyalgia rheumatica and liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Unusual electromyographic findings in a patient with polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

The therapeutic impact of temporal artery biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

ARTERITIS IN "POLYMYALGIA RHEUMATICA"

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Presentation of occult giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Giant-cell (temporal) arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Prognosis and management of polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Abnormal radionuclide liver scans in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Rarity of synovitis in polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Liver scan abnormalities in polymyalgia rheumatica/giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Temporal arteriography. Analysis of 21 cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Hepatocellular disease in the giant-cell arteritis/polymyalgia rheumatica syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Polymyalgia rheumatica and liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Serum levels of immunoglobulin and complement in giant-cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Immune complexes, rheumatoid factors, and cellular immunological parameters in patients with giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Temporal (granulomatous) arteritis: a histopathological study of 32 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Cranial arteritis with liver involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Hepatic artery involvement in polymyalgia arteritica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Sternoclavicular erosions in polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

An additional test for the diagnosis and monitoring of giant cell arteritis and polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Immunological and histological study of temporal arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Giant-cell arteritis, or arteritis of the aged

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

The prevalence of rheumatoid arthritis in the Sultanate of Oman

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Polymyalgia rheumatica and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Polymyalgia rheumatica and antimitochondrial antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Combined temporal arteriography and selective biopsy in suspected giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Polymyalgia Rheumatica, Arteritis and Hepatic Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Clinical usefulness of temporal artery biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Liver involvement in polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

1 reference

7 January 2021

Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980066-4

7 January 2021

Temporal arteritis in Israel. A review of 47 patients

23

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

Liver dysfunction and polymyalgia rheumatica. A case report

30 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

Anticardiolipin and antineutrophil antibodies in giant cell arteritis

30 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

Joint imaging in polymyalgia rheumatica

30 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

Serological and immunohistochemical determination of von Willebrand factor antigen in serum and biopsy specimens from patients with arteritis temporalis and polymyalgia rheumatica

30 November 2022

67

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

Light and electron microscopic studies on human temporal arteries with special reference to alterations related to senescence, atherosclerosis and giant cell arteritis

30 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

Diagnostic value of the history and examination in giant cell arteritis: a clinical pathological study of 81 temporal artery biopsies

30 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

Nonclassical organ involvement in temporal arteritis

30 November 2022

84

1 reference

https://api.crossref.org/works/10.1016/S0950-3579(05)80066-4

30 November 2022

Identifiers

1 reference

17 August 2017

1 reference